Abstract
Although most insulinomas are located in the pancreas, very rare ectopic cases have been described in the spleen, perisplenic tissue, duodenohepatic ligament, and adjacent to the ligament of Treitz. Moreover, three cases located in the duodenum have also been reported in the English literature. Ectopic insulinomas represent challenging neoplasms with clinical implications mainly due to the difficulties in their pre-operatory diagnosis and localization. In the present paper, we describe the fourth ectopic duodenal insulinoma so far reported. A 75-year-old woman presented at clinical observation due to neuroglycopenic symptoms that disappeared after glucose intake. Tumor was localized in the second portion of the duodenum in front of the papilla of Vater and was surgically enucleated. Microscopically, it was composed of monomorphic cells with eosinophilic cytoplasm arranged in trabecular and lobular patterns and diffusely positive for insulin, proinsulin, amylin, and PDX1. About 30 % of tumor cells also showed immunoreactivity for somatostatin, while no positivity for glucagon, pancreatic polypeptide, gastrin, serotonin, and somatostatin receptor subtype 2A was found. The Ki67 proliferative index was 1 %. We have also reviewed the literature on this topic to give the reader a comprehensive overview of this very rare tumor type.
Similar content being viewed by others
References
Capella C, Arnold R, Klimstra DS, et al. (2010) Neuroendocrine neoplasms of the small intestine. In: Bosman, FT, Carneiro F, Hruban RH, Theise ND (eds.) WHO classification of tumors of the digestive system. IARC Press, Lyon, pp 102–107.
Soga J (2003) Endocrinocarcinomas (carcinoids and their variants) of the duodenum. An evaluation of 927 cases. J Exp Clin Cancer Res 22:349–363.
Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM (2011) The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin N Am 40:1–18.
Capella C, Riva C, Rindi G, et al. (1991) Histopathology, hormone products, and clinicopathological profile of endocrine tumor of the upper small intestine: a study of 44 cases. Endocr Pathol 2:92–110.
Karasawa Y, Sakaguchi M, Minami S, et al. (2001) Duodenal somatostatinoma and erythrocytosis in a patients with von Hippel–Lindau disease type 2A. Inter Med 40:38–43.
Komminoth P, Perren A, Öberg K, Rindi G, Heitz PU, Klöppel G. (2004) Insulinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumors of endocrine organs. IARC Press, Lyon, pp 183–186.
Stefanini P, Carboni M, Patrassi N, Basoli A (1974) Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 75:597–609.
Cárdenas CM, Domínguez I, Campuzano M, et al. (2009) Malignant insulinoma arising from intrasplenic heterotopic pancreas. JOP 10:321–323.
Yoshikawa K, Wakasa H (1980) Hypoglycemia associated with aberrant insulinoma: a case report of 16 years follow-up. Tohoku J Exp Med 132:17–29.
Xiang-Ling W, Yi-Ming M, Jing-Tao D, Wen-Wen Z, Zhao-Hui L, Ju-Ming L (2011) Successful laparoscope resection of ectopic insulinoma in duodenohepatic ligament. Am J Med Sci 341:420–422.
Hennings J, Garske U, Botling J, Hellman P (2005) Malignant insulinoma in ectopic pancreatic tissue. Dig Surg 22:377–379.
Watanabe W, Kurumada T, Shirai T, Tsutsumi Y (1995) Aberrant insulinoma of the duodenal bulb. Pathol Int 45:895–900.
Miyazaki K, Funakoshi A, Nishihara S, Wasada T, Koga A, Ibayashi H (1986) Aberrant insulinoma in the duodenum. Gastroenterology 90:1280–1285.
Tolentino LF, Lee H, Maung T, Stabile BE, Li K, French SW (2004) Islet cell tumor arising from a heterotopic pancreas in the duodenal wall with ulceration. Exp Mol Pathol 76:51–56.
Rindi G, Arnold R, Bosman FT, et al. (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman, FT, Carneiro F, Hruban RH, Theise ND (eds.) WHO classification of tumors of the digestive system. 2010 IARC Press, Lyon, 13–14.
Solcia E, Kloppel G, Sobin LH (2000) Histological typing of endocrine tumors. 2nd edn. Springer-Verlag, Berlin
Rindi G, Falconi M, Klersy C, et al. (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104:764–777.
La Rosa S, Furlan D, Sessa F, Capella C (2010) The endocrine pancreas. In: Lloyd RV (ed) Differential diagnosis and molecular advances, 2nd edn. Springer, New York, pp 367–413
Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B-cell secretory granules of the human pancreatic islets. Diabetologia 32:240–244.
Srivastava A, Hornick JL (2009) Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 33:626–632.
Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al. (2004) Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 28:1145–1153.
La Rosa S, Rigoli E, Uccella S, Novario R, Capella C (2007) Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumors. Histopathology 50:597–606.
Portela-Gomes GM, Stridsberg M, Grinelius L, Rorstad O, Janson ET (2007) Differential expression of the somatostatin receptor subtypes in human benign and malignant insulinomas—predominance of receptor subtype 4. Endocr Pathol 18:79–85.
Smith FG, Ohio M (1942) Aberrant pancreatic tissue with hyperinsulinism. JAMA 118:454–455.
Roggli VL, Judge DM, McGavran MH (1979) Duodenal glucagonoma: a case report. Hum Pathol 10:350–353.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
La Rosa, S., Pariani, D., Calandra, C. et al. Ectopic Duodenal Insulinoma: A Very Rare and Challenging Tumor Type. Description of a Case and Review of the Literature. Endocr Pathol 24, 213–219 (2013). https://doi.org/10.1007/s12022-013-9262-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-013-9262-y